highly significantP < .0001
Furthermore, the median survival time (TTH) of Surgicel was lower than that of Arista, PerClot, and 4DryField, and the log-rank test showed that the difference in time to achieve hemostasis between Surgicel and each of the test articles was also highly significant ( P < .0001; Supplementary Table S3 ).